课题基金 / 基金详情

Irisin通过调控中性粒细胞线粒体Mg2+动力学抑制线粒体ROS诱导形成胞外陷阱从而拮抗脓毒症肺损伤的作用及机制研究

批准号:
82102267
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
严心
依托单位:
学科分类:
脓毒症
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
严心

项目摘要

结项摘要

相似基金

相关文献

中文摘要
Irisin是可调节线粒体功能的新内源性肌肉因子。中性粒细胞(PMN)产生NETs是脓毒症肺损伤进展的核心机制,其线粒体功能障碍是NETs形成的关键机制。我们已发现Irisin保护心脏肥大,但不知其对脓毒症肺损伤的作用。预实验显示Irisin敲除加重脓毒症小鼠死亡和肺损伤、增加PMN浸润和NETs,Irisin过表达缓解这些病变。我们构建Irisin RESCUE的Irisin敲除小鼠,以盲肠结扎穿孔诱导脓毒症,LPS诱导原代小鼠骨髓来源PMN或HL-60类PMN发生NETs,探究Irisin拮抗脓毒症肺损伤的具体机制;利用荧光素酶报告系统、EMSA及ChIP等实验阐明Irisin通过其受体及受体后信号调节NF-κB,进而调控PMN线粒体镁离子(Mg2+)转运蛋白Mrs2的转录和表达,减低线粒体内Mg2+浓度缓解Mg2+过载和氧化应激,抑制NETs的形成,从而拮抗脓毒症肺损伤的创新机制。
英文摘要
Irisin is a new endogenous myokine that can regulate mitochondrial function. NETs derived from neutrophil (PMN) play a central role in the progression of septic lung injury, and PMNs’ mitochondrial dysfunction is the key mechanism for NETs formation. We've cognized that irisin protected cardiac hypertrophy, but knew nothing about its effect on septic lung injury. Our preparatory experiments showed that irisin deficiency aggravated mortality and lung injury in septic mice, accompanied with a significant increase in PMN infiltration and NETs formation in lung tissues, which were attenuated by irisin overexpression. Here, we try to reveal the specific mechanisms underlying the protection of irisin against septic lung injury. We will generate exogenous irisin-RESCUED mice with endogenous irisin knockout, and induce sepsis in them by using cecal ligation and puncture; and we will culture PMN derived from WT mouse bone marrow or HL-60, and induce NETs in them by exposing to LPS. We further perform luciferase reporter, EMSA and ChIP assays to elucidate whether irisin protects septic lung injury through a unique mechanism, in which irisin inhibit NETs formation induced by oxidative stress following Mg2+ overload stirred by LPS in mitochondria. We try to further identify that whether NF-κB, an inflammatory-related transcription factor, is inhibited by irisin through its special receptors and post-receptor signaling in PMN, and then the transcription and expression of Mrs2, an Mg2+ transporter in mitochondria, are suppressed by irisin-reduced transcription activity of NF-κB.
脓毒症是由宿主对感染的反应失调导致的危及生命的器官功能障碍。肺组织是脓毒症发生进展过程中易受损的器官之一。中性粒细胞产生胞外陷阱(NETs)是脓毒症肺损伤进展的核心机制,其线粒体功能障碍是NETs形成的关键机制。Irisin是一种心脏组织高表达的肌肉来源的肽类激素,由 III 型纤维蛋白组件包含蛋白 5 (fibronectin type III domain containing protein 5 FNDC5)在肌细胞膜上经过蛋白水解剪切为多肽片段。Irisin已被证实能够调节线粒体功能和氧化应激,但目前尚不清楚 Irisin调节脓毒症肺损伤关键细胞中性粒细胞NETs形成的作用及分子机制。本项目主要探讨内源性Irisin缓解脓毒症关键性病理变化,即肺组织中性粒细胞NETs形成的作用和具体机制。我们采用盲肠结扎穿孔方法构建小鼠脓毒症动物模型,观察到动物模型中脓毒症小鼠骨骼肌Irisin水平明显下降,小鼠死亡增加、肺组织中性粒细胞浸润增加,肺组织炎症因子水平增加,NETs形成增加。Irisin基因敲除加重脓毒症肺损伤,而Irisin过表达则显著缓解这些损伤。同时以LPS诱导原代小鼠骨髓来源PMN或HL-60类PMN形成NETs,观察到外源性Irisin处理可以缓解LPS诱导的中性粒细胞ROS,减少中性粒细胞无氧酵解,减少线粒体内Mg2+水平。机制研究方面,我们发现Irisin通过调节ERK激酶信号通路,降低中性粒细胞胞核p65磷酸化水平及iκB磷酸化水平,进而减少线粒体Mg2+转运体Mrs2表达,减低中性粒细胞线粒体Mg2+水平,减轻线粒体ROS水平,最终减少中性粒细胞NETs的形成,缓解脓毒症肺损伤。本研究阐明一种全新的脓毒症内源性保护机制—肌肉因子Irisin通过肌肉分泌和血循环递送,实现肌肉与肺组织之间不同器官协同互作的创新调节机制,为脓毒症疾病的防治提供新的治疗靶点和策略。
国内基金
海外基金